Navigation Links
AbbeyMoor Medical Receives Category I CPT(R) Code for The Spanner(TM) Prostatic Stent Procedure
Date:10/14/2009

about the stent in Urology Times (July 2009): "How to manage BOO (bladder outlet obstruction) with temporary prostatic stenting."

The relative value units (RVUs) used to establish the payment amounts for The Spanner procedure will be published by the Centers for Medicare and Medicaid Services in the Federal Register later this fall. CPT code 53855 will replace Category III CPT code 0084T, effective January 1, 2010.

About CPT Coding

In addition to facilitating reimbursement in government programs such as Medicare and Medicaid, CPT codes are used by other insurance companies and government payers to describe health care services and procedures. In the development of new and revised Category I CPT codes the AMA requires:

  • That the service/procedure receive approval/clearance from the FDA
  • That the service/procedure is performed across the country in multiple locations
  • That many physicians perform the service/procedure
  • That the clinical efficacy for the service/procedure has been well established and documented.

More information about CPT codes and the process of establishing CPT codes is available at the AMA's website: www.AMA-Assn.org

About The Spanner

The Spanner is a temporary prostatic stent designed to aid men who are experiencing difficulty in urination following a minimally invasive treatment for their BPH. Device placement can be safely performed in a physician's office and does not require cystoscopy or anesthesia. The Spanner is approved by the FDA for use up to 30 days in patients who have undergone minimally invasive treatment for benign prostatic hyperplasia following initial post treatment catheterization.

About AbbeyMoor Medical

AbbeyMoor Medical is a privately held company that develops and manufactures innovative medical devices
'/>"/>

SOURCE AbbeyMoor Medical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Solta Medical Announces FDA 510(k) Clearance of New Fraxel re:store(R) Dual Laser System
2. Breast Cancer Survivors and Patients Encouraged to Have Medical History Readily Available
3. Timm Medical Technologies and Ferring Pharmaceuticals Enter Exclusive Co-Promotion Agreement for Prosed(R) DS
4. Cardiva Medical, Inc. Announces the Departure of its President and his Appointment as CEO of Innovative Energy, Inc.
5. Vibrant Exhibit Hall Features Innovative Medical Technology at AdvaMed 2009
6. Luminous Medical, Inc. Secures Exclusive Rights to Glucose Sensor for Its Automated Glucose Monitor
7. Growing Supply Chain Complexity Increasing Impact on Medical Device Company Operations
8. Award-Winning Medical Technology From Germany
9. Cantel Medicals Crosstex Subsidiary Launches New Specially Treated Face Mask Effective Against H1N1 Influenza
10. ATS Medical Announces Receipt of CE Mark for the New ATS CryoMaze 10-S Probe
11. Sonitus Medical Technology Ranks #1 on Cleveland Clinics Top 10 Medical Innovations for 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... , Feb. 26, 2015 Every year ... research to fight heart disease.  Nevertheless, year after year ... ElectroCardioGrams (EKG) as the first test to determine the ... have chest pain or not, even though that technology ... despite the fact that doctors know, (while most patients ...
(Date:2/26/2015)... Mass. , Feb. 26, 2015  Spring ... novel therapeutics for the treatment of Hepatitis B ... the closing of a $22 million financing. Funds ... SB 9200, a novel, broad spectrum antiviral agent ... nucleic acid hybrid (SMNH) chemistry platform, into Phase ...
(Date:2/26/2015)... 26, 2015  Lyric Pharmaceuticals Inc. today announced the ... $20.4 million. The financing, co-led by RiverVest Venture Partners, ... Aperture Venture Partners. Lyric is a ... Wurtman , M.D., M.B.A., President & Chief Executive Officer ... Officer.  In 2014, Lyric closed a seed financing round ...
Breaking Medicine Technology:National Heart Health Month In February 2Spring Bank Pharmaceuticals Completes $22 Million Financing 2
... NEW YORK, Sept. 13, 2011 IMMUNE ... based Therapeutics for the treatment of inflammatory diseases and ... M.D., Ph.D., to the position of Chief Medical Officer.  ... pivotal  role in the development of Bertilimumab, IMMUNE,s phase ...
... DIEGO, Sept. 13, 2011 Sequenom, Inc. (NASDAQ: ... solutions, today announced the Company,s participation at the UBS Global ... in New York City September 19-21, 2011. ... Development, will present on Monday, September 19, 2011 beginning at ...
Cached Medicine Technology:IMMUNE Pharmaceuticals Announces Alan G. Harris MD, PhD, FRCP as Chief Medical Officer 2IMMUNE Pharmaceuticals Announces Alan G. Harris MD, PhD, FRCP as Chief Medical Officer 3Sequenom Announces Participation at UBS Global Life Sciences Conference 2
(Date:2/27/2015)... 27, 2015 The decision to relocate US ... facilities and to make camp more accessible to campers outside ... a Contact Football Camp. The fields are in premier condition ... country,” states Mike de Surville, vice president of US Sports ... of experienced coaches with the passion to create a program ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 RDI-Engineering will ... Mind: Pi Day event on March 14, at Moreno ... services, demonstrations on how to use engineering software and ... will be hosted by Moreno Valley College’s Upward Bound ... Success Center (SSC) in hopes to encourage students to ...
(Date:2/27/2015)... 27, 2015 Is it reasonable – and ... practices and games, and possible to do so without causing ... sports might be at high risk for concern and could ... the issues being addressed by two introductory bills, Int. ... hearing last month in New York City. More specifically, ...
(Date:2/27/2015)... February 27, 2015 Many mattresses ... people’s health. Mercola.com has introduced organic cotton mattresses ... toxic flame retardant chemicals. Dr. Mercola’s Healthy Home ... and better materials. Organic cotton is significantly less ... organic bedding products are made by Naturepedic and ...
(Date:2/27/2015)... According to a Feb. 12, 2015 news release ... treat cancer by killing cancer stem cells, has received orphan ... for use in the treatment of mesothelioma.* According to the ... encourage the development of drugs for the treatment of rare ... decision,” said Melinda Helbock, Founder of The Law Office of ...
Breaking Medicine News(10 mins):Health News:US Sports Camps Football Camps Announce New Contact Football Camp Northeast Location 2Health News:RDI-Engineering Participates in STEM”U”LATE Your Mind Event to Host Educational Exhibition 2Health News:NYSATA Athletic Trainers Provide Expert Testimony at NYC Youth Concussion and Sports Safety Hearing 2Health News:NYSATA Athletic Trainers Provide Expert Testimony at NYC Youth Concussion and Sports Safety Hearing 3Health News:New Drug Receives FDA Approval as Orphan Drug for the Treatment of Mesothelioma 2Health News:New Drug Receives FDA Approval as Orphan Drug for the Treatment of Mesothelioma 3
... March 23 (HealthDay News) -- A new study helps ... drug therapy. Researchers at the Massachusetts General Hospital ... non-small cell lung cancer, the leading cause of cancer ... with resistance. They also confirmed resistance-related genetic changes ...
... Concordia University have pioneered a computer-based method to detect ... that may open a window on the brain,s electrical ... Detection of Epileptic Seizures," presented at the annual meeting ... the very successful application of this new seizure-detection method. ...
... in French . The human brain loses 5 ... 90 years old. While some cells are lost, the brain is ... results of her most recent clinical study published today in the ... Sylvie Belleville, PhD in neuropsychology, the principal author of this study ...
... will convene in Chicago this week to present new ... detect, treat, prevent and cure osteoarthritis (OA), which affects ... the Segal North American Osteoarthritis Workshop (SNOW) on March ... as those that follow joint trauma, obesity and the ...
... who take statin drugs commonly used to lower cholesterol ... their cancer return than patients who do not take ... March issue of the International Journal of Radiation OncologyBiologyPhysics, ... Oncology (ASTRO). , In the study, 1,681 men with ...
... March 22 (HealthDay News) -- Trauma injury patients who arrive ... no more likely to die than those who arrive on ... contrast with previous research that said patients with health emergencies ... they arrive at the hospital at night or on weekends. ...
Cached Medicine News:Health News:Lung Cancer Evolves With Treatment, Study Finds 2Health News:New way to detect epileptic seizures 2Health News:Subjects at risk of Alzheimer's may now be able to delay the onset of their first symptoms 2Health News:Researchers explore new treatments to end OA 2Health News:Trauma Patients Seem More Likely to Survive on Weekends 2
Each slide contains a gram positive control of Staphylococcus aureus ATCC ® 25923 and a gram negative control of Escherichia coli ATCC ® 25922....
Each slide contains an A.F.B. positive staining control of Mycobacterium scrofulaceum ATCC ® 19981 in simulated sputum and an A.F.B. negative staining control of Escherichia coli ATCC ® 25922...
... Plate Capability The Equalizer 384 includes ... and equal tip spacing, choice of two software ... addition, this model allows you to evenly space ... accessing many gels and for use with 384 ...
... 384 Well Plate Capability The Equalizer ... original Equalizerexpandable and equal tip spacing, choice of ... capabilities. In addition, this model allows you to ... loading and accessing many gels and for use ...
Medicine Products: